Category: CAR T-Cell therapy

Home / CAR T-Cell therapy

Categories

Personalized T-Cell therapies in the treatment of hematological malignancies

 IntroductionCancer is still one of the most difficult diseases to cure, and conventional treatments such as chemotherapy, radiation, and surgery have yielded limited success and severe side effects....

Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment

 CAR immune Cell therapyChimeric Antigen Receptor (CAR) immune cell therapy has transformed the treatment of cancer, especially for hematological cancers. Its effectiveness notwithstanding, it still ...

How to prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies?

 CAR T Cell therapyChimeric Antigen Receptor (CAR) T-cell therapy has changed the face of treating B-cell malignancies, and it has provided hope to those with relapsed or refractory disease. Through ...

Donor T cells for CAR T cell therapy

 CAR T Cell therapyChimeric Antigen Receptor (CAR) T cell therapy has transformed cancer treatment by genetically modifying a patient's own T cells to target and destroy cancer cells. Although this a...

Strategies to optimize chimeric antigen receptor T-cell therapy in hematologic malignancies: Experience from China

 CAR T Cell therapyChimeric Antigen Receptor (CAR) T-cell therapy has changed the course of treatment for numerous hematologic malignancies like leukemia, lymphoma, and multiple myeloma. China is at ...

CAR T-cell therapies in China: A Journey of Rapid Growth and Promise

The rise of CAR T Cell therapy in ChinaChina's journey with CAR T-cell therapy began in 2013 with the first clinical trials. Since then, the country has witnessed an exponential growth in this field, ...

Limkato: Korea’s first CAR T Cell therapy

CAR T Cell therapy in KoreaCAR T cell therapy is an advanced cancer treatment that has gained significant momentum in South Korea. It involves genetically modifying a patient’s T cells to recognize ...

CAR T Cell therapy for breast cancer in China

Understanding CAR T Cell therapyCAR T-cell therapy involves modifying the T cells from a patient, which are part of the immune system, to carry receptors that specifically target cancer cells. Once th...

CAR T Cell therapy for pancreatic cancer in China

Understanding pancreatic cancerPancreatic cancer is recognized as one of the most aggressive and lethal cancers, largely due to the fact that it tends to be diagnosed at a late stage. The pancreas, a ...

CAR T Cell Therapy for Glioblastoma in China: A Revolutionary Approach to Brain Tumor Treatment

GBMThe glioblastoma multiforme (GBM) is considered the most aggressive and lethal type of brain tumor. Despite treatments that include surgery, radiation, and chemotherapy, it has an unfavorable progn...

Scan the code